CEBPA and neoplasm: Other P19- and P1-CCAAT/enhancer-binding Protein α (C/EBPα)-saRNA conjugates also indicated strong suppression of PANC-1 cell proliferation and reduced tumor size up to 30% with no observed toxicity in gemcitabine-resistant AsPC-1 cells mouse-xenografts (Yoon et al., 2016b).